OtherClinical Practice Guidelines
Open Access

Defining Clinical Indications of Proton Beam Therapy at National Level in the Kingdom of Saudi Arabia

Hussain AlHussain, Ali Balbaid, Robert Malyapa, Majid AlOthman, Yasser A. Bahadur, Mutahir A. Tunio and Mushabbab Al Asiri
Saudi Medical Journal September 2019, 40 (9) 879-886; DOI: https://doi.org/10.15537/smj.2019.9.24496

References

  1. ↵
    1. Underwood T,
    2. Paganetti H
    (2016) Variable proton relative biological effectiveness:How do we move forward? Int J Radiat Oncol Biol Phys 95:56–58.
    OpenUrl
  2. ↵
    1. Moteabbed M,
    2. Yock TI,
    3. Depauw N,
    4. Madden TM,
    5. Kooy HM,
    6. Paganetti H
    (2016) Impact of spot size and beam-shaping devices on the treatment plan quality for pencil beam scanning proton therapy. Int J Radiat Oncol Biol Phys 95:190–198.
    OpenUrl
  3. ↵
    1. Cox JD
    (2016) Impediments to Comparative Clinical Trials with Proton Therapy. Int J Radiat Oncol Biol Phys 95((1):4–8, doi:10.1016/j.ijrobp.2015.09.03624.
    OpenUrl
  4. ↵
    1. Particle Therapy Co-Operative Group (PTCOG)
    (2018) Home/facilities in operation (PTCOG, Villigen (SW)).
  6. ↵
    1. Saudi Research & Publishing Company
    Riyadh to have proton therapy center, cited 2012, Available from: http://www.arabnews.com/node/404016.
  7. ↵
    1. World Health Organization
    WHO Handbook for Guideline Development, cited 2016s, Available from: http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf.
  8. ↵
    1. Shields J,
    2. Shields C
    1. Shields J,
    2. Shields C
    (1992) in Intraocular tumors:A text and atlas, Introduction to melanocytic tumors of the uvea, eds Shields J, Shields C (WB Saunders, Philadelphia (PA)), pp 45–59.
  9. ↵
    1. Caujolle JP,
    2. Mammar H,
    3. Chamorey E,
    4. Pinon F,
    5. Herault J,
    6. Gastaud P
    (2010) Proton beam radiotherapy for uveal melanomas at nice teaching hospital:16 years'experience. Int J Radiat Oncol Biol Phys 78:98–103.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Damato B,
    2. Kacperek A,
    3. Chopra M,
    4. Campbell IR,
    5. Errington RD
    (2005) Proton beam radiotherapy of choroidal melanoma:The Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys 62:1405–1411.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Hug EB,
    2. Slater JD
    (2000) Proton radiation therapy for chordomas and chondrosarcomas of the skull base. Neurosurg Clin N Am 11:627–638.
    OpenUrlPubMedWeb of Science
  12. ↵
    1. Weber DC,
    2. Murray F,
    3. Combescure C,
    4. Calugaru V,
    5. Alapetite C,
    6. Albertini F,
    7. et al.
    (2018) Long term outcome of skull-base chondrosarcoma patients treated with high-dose proton therapy with or without conventional radiation therapy. Radiother Oncol 129:520–526.
    OpenUrl
  13. ↵
    1. Munzenrider JE,
    2. Liebsch NJ
    (1999) Proton therapy for tumors of the skull base. Strahlenther Onkol 175(Suppl 2):57–63.
    OpenUrlPubMedWeb of Science
  14. ↵
    1. Rutz HP,
    2. Weber DC,
    3. Sugahara S,
    4. Timmermann B,
    5. Lomax AJ,
    6. Bolsi A,
    7. et al.
    (2007) Extracranial chordoma:Outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation. Int J Radiat Oncol Biol Phys 67:512–520.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Rotondo RL,
    2. Folkert W,
    3. Liebsch NJ,
    4. Chen YL,
    5. Pedlow FX,
    6. Schwab JH,
    7. et al.
    (2015) High-dose proton-based radiation therapy in the management of spine chordomas:outcomes and clinicopathological prognostic factors. J Neurosurg Spine 23:788–797.
    OpenUrl
  16. ↵
    1. Weber DC,
    2. Schneider R,
    3. Goitein G,
    4. Koch T,
    5. Ares C,
    6. Geismar JH,
    7. et al.
    (2012) Spot scanning-based proton therapy for intracranial meningioma:long-term results from the Paul Scherrer Institute. Int J Radiat Oncol Biol Phys 83:865–871.
    OpenUrlCrossRefPubMed
  17. ↵
    1. McDonald MW,
    2. Plankenhorn DA,
    3. McMullen KP,
    4. Henderson MA,
    5. Dropcho EJ,
    6. Shah MV,
    7. et al.
    (2015) Proton therapy for atypical meningiomas. J Neurooncol 123:123–128.
    OpenUrl
  18. ↵
    1. Fukumitsu N,
    2. Sugahara S,
    3. Nakayama H,
    4. Fukuda K,
    5. Mizumoto M,
    6. Abei M,
    7. et al.
    (2009) A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 74:831–836.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Mizumoto M,
    2. Okumura T,
    3. Hashimoto T,
    4. Fukuda K,
    5. Oshiro Y,
    6. Fukumitsu N,
    7. et al.
    (2011) Proton beam therapy for hepatocellular carcinoma:a comparison of three treatment protocols. Int J Radiat Oncol Biol Phys 81:1039–1045.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Sugahara S,
    2. Oshiro Y,
    3. Nakayama H,
    4. Fukuda K,
    5. Mizumoto M,
    6. Abei M,
    7. et al.
    (2010) Proton beam therapy for large hepatocellular carcinoma. >Int J Radiat Oncol Biol Phys 76:460–466.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Kopecky AS,
    2. Khan AJ,
    3. Pan W,
    4. Drachtman R,
    5. Parikh RR
    (2017) Outcomes and patterns of care in a nationwide cohort of pediatric medulloblastoma:Factors affecting proton therapy utilization. Adv Radiat Oncol 2:588–596.
    OpenUrl
  22. ↵
    1. Eaton BR,
    2. Esiashvili N,
    3. Kim S,
    4. Patterson B,
    5. Weyman EA,
    6. Thornton LT,
    7. et al.
    (2016) Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma. Neuro Oncol 18:881–887.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Brodin NP,
    2. Munck Af,
    3. Rosenschöld P,
    4. Aznar MC,
    5. Kiil-Berthelsen A,
    6. Vogelius IR,
    7. Nilsson P,
    8. et al.
    (2011) Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncol 50:806–816.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Brown AP,
    2. Barney CL,
    3. Grosshans DR,
    4. McAleer MF,
    5. de Groot JF,
    6. Puduvalli VK,
    7. et al.
    (2013) Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma. Int J Radiat Oncol Biol Phys 86:277–284.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Yock TI,
    2. Yeap BY,
    3. Ebb DH,
    4. Weyman E,
    5. Eaton BR,
    6. Sherry NA,
    7. et al.
    (2016) Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma:a phase 2 single-arm study. Lancet Oncol 17:287–298.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Mizumoto M,
    2. Oshiro Y,
    3. Takizawa D,
    4. Fukushima T,
    5. Fukushima H,
    6. Yamamoto T,
    7. et al.
    (2015) Proton beam therapy for pediatric ependymoma. Pediatr Int 57:567–571.
    OpenUrl
  27. ↵
    1. Macdonald SM,
    2. Sethi R,
    3. Lavally B,
    4. Yeap BY,
    5. Marcus KJ,
    6. Caruso P,
    7. et al.
    (2013) Proton radiotherapy for pediatric central nervous system ependymoma:clinical outcomes for 70 patients. Neuro Oncol 15:1552–1559.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Leiser D,
    2. Calaminus G,
    3. Malyapa R,
    4. Bojaxhiu B,
    5. Albertini F,
    6. Kliebsch U,
    7. et al.
    (2016) Tumour control and Quality of Life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy. Radiotherapy Oncology 120:163–168.
    OpenUrl
  29. ↵
    1. Indelicato DJ,
    2. Rotondo RL,
    3. Uezono H,
    4. Sandler ES,
    5. Aldana PR,
    6. Ranalli NJ,
    7. et al.
    (2019) Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma. Int J Radiat Oncol Biol Phys 104:149–156.
    OpenUrl
  30. ↵
    1. Dulguerov P,
    2. Jacobsen MS,
    3. Allal AS,
    4. Lehmann W,
    5. Calcaterra T
    (2001) Nasal and paranasal sinus carcinoma:are we making progress?A series of 220 patients and a systematic review. Cancer 92:3012–3029.
    OpenUrlCrossRefPubMedWeb of Science
  31. ↵
    1. Zenda S,
    2. Kohno R,
    3. Kawashima M,
    4. Arahira S,
    5. Nishio T,
    6. Tahara M,
    7. et al.
    (2011) Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 81:1473–1478.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Fukumitsu N,
    2. Okumura T,
    3. Mizumoto M,
    4. Oshiro Y,
    5. Hashimoto T,
    6. Kanemoto A,
    7. et al.
    (2012) Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam. Int J Radiat Oncol Biol Phys 83:704–711.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Truong MT,
    2. Kamat UR,
    3. Liebsch NJ,
    4. Curry WT,
    5. Lin DT,
    6. Barker FG 2nd.,
    7. et al.
    (2009) Proton radiation therapy for primary sphenoid sinus malignancies:treatment outcome and prognostic factors. Head Neck 31:1297–1308.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Feehan PE,
    2. Castro JR,
    3. Phillips TL,
    4. Petti P,
    5. Collier JM,
    6. Daftari I,
    7. et al.
    (1992) Recurrent locally advanced nasopharyngeal carcinoma treated with heavy charged particle irradiation. Int J Radiat Oncol Biol Phys 23:881–884.
    OpenUrlPubMed
  35. ↵
    1. Romesser PB,
    2. Cahlon O,
    3. Scher ED,
    4. Hug EB,
    5. Sine K,
    6. DeSelm C,
    7. et al.
    (2016) Proton Beam Reirradiation for Recurrent Head and Neck Cancer:Multi-institutional Report on Feasibility and Early Outcomes. Int J Radiat Oncol Biol Phys 95:386–395.
    OpenUrl
  36. ↵
    1. Boimel PJ,
    2. Berman AT,
    3. Li J,
    4. Apisarnthanarax S,
    5. Both S,
    6. Lelionis K,
    7. et al.
    (2017) Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma. J Gastrointest Oncol 8:665–674.
    OpenUrl
  37. ↵
    1. Vernimmen FJ,
    2. Mohamed Z,
    3. Slabbert JP,
    4. Wilson J
    (2009) Long-term results of stereotactic proton beam radiotherapy for acoustic neuromas. Radiother Oncol 90:208–212.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Weber DC,
    2. Chan AW,
    3. Bussiere MR,
    4. Harsh GR 4th.,
    5. Ancukiewicz M,
    6. Barker FG 2nd.,
    7. et al.
    (2003) Proton beam radiosurgery for vestibular schwannoma:tumor control and cranial nerve toxicity. Neurosurgery 53:577–586.
    OpenUrlPubMed
  39. ↵
    1. Dennis ER,
    2. Bussiere MR,
    3. Niemierko A,
    4. Lu MW,
    5. Fullerton BC,
    6. Loeffler JS,
    7. et al.
    (2013) A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy. Technol Cancer Res Treat 12:1–9.
    OpenUrlCrossRefPubMed
  40. ↵
    1. Shih HA,
    2. Sherman JC,
    3. Nachtigall LB,
    4. Colvin MK,
    5. Fullerton BC,
    6. Daartz J,
    7. et al.
    (2015) Proton therapy for low-grade gliomas:Results from a prospective trial. Cancer 121:1712–1719.
    OpenUrlCrossRefPubMed
  41. ↵
    1. Thurin E,
    2. Nystrom PW,
    3. Smits A,
    4. Werlenius K,
    5. Black A,
    6. Liljegren A,
    7. et al.
    (2018) Proton therapy for low-grade gliomas in adults:A systematic review. Clin Neurol Neurosurg 174:233–238.
    OpenUrl
  42. ↵
    1. Nakayama H,
    2. Satoh H,
    3. Sugahara S,
    4. Kurishima K,
    5. Tsuboi K,
    6. Sakurai H,
    7. et al.
    (2011) Proton beam therapy of Stage II and III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 81:979–984.
    OpenUrlCrossRefPubMed
    1. Chang JY,
    2. Komaki R,
    3. Lu C,
    4. Wen HY,
    5. Allen PK,
    6. Tsao A,
    7. et al.
    (2011) Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III non-small cell lung cancer. Cancer 117:4707–4713.
    OpenUrlCrossRefPubMedWeb of Science
  44. ↵
    1. Nichols RC Jr.,
    2. George TJ,
    3. Zaiden RA Jr.,
    4. Awad ZT,
    5. Asbun HJ,
    6. Huh S,
    7. et al.
    (2013) Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Acta Oncol 52:498–505.
    OpenUrl
  45. ↵
    1. Sugahara S,
    2. Tokuuye K,
    3. Okumura T,
    4. Nakahara A,
    5. Saida Y,
    6. Kagei K,
    7. et al.
    (2005) Clinical results of proton beam therapy for cancer of the esophagus. Int J Radiat Oncol Biol Phys 61:76–84.
    OpenUrlCrossRefPubMed
  46. ↵
    1. Ishikawa H,
    2. Hashimoto T,
    3. Moriwaki T,
    4. Hyodo I,
    5. Hisakura K,
    6. Terashima H,
    7. et al.
    (2015) Proton beam therapy combined with concurrent chemotherapy for esophageal cancer. Anticancer Res 35:1757–1762.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Radu C,
    2. Norrlid O,
    3. Brændengen M,
    4. Hansson K,
    5. Isacsson U,
    6. Glimelius B
    (2013) Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients. Acta Oncol 52:528–537.
    OpenUrl
  48. ↵
    1. DeLaney TF,
    2. Liebsch NJ,
    3. Pedlow FX,
    4. Adams J,
    5. Dean S,
    6. Yeap BY,
    7. et al.
    (2009) Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 74:732–739.
    OpenUrlCrossRefPubMed
  49. ↵
    1. Li J,
    2. Dabaja B,
    3. Reed V,
    4. Allen PK,
    5. Cai H,
    6. Amin MV,
    7. et al.
    (2011) Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. Int J Radiat Oncol Biol Phys 81:167–174.
    OpenUrlCrossRefPubMed
  50. ↵
    1. Hoppe BS,
    2. Flampouri S,
    3. Zaiden R,
    4. Slayton W,
    5. Sandler E,
    6. Ozdemir S,
    7. et al.
    (2014) Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma:results of a phase 2 study. Int J Radiat Oncol Biol Phys 89:1053–1059.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section